LEADER 04336nam 22005774a 450 001 9910809427203321 005 20200520144314.0 010 $a9786612485084 010 $a1-60473-037-4 010 $a1-282-48508-3 035 $a(CKB)1000000000521668 035 $a(SSID)ssj0000285093 035 $a(PQKBManifestationID)11248344 035 $a(PQKBTitleCode)TC0000285093 035 $a(PQKBWorkID)10278445 035 $a(PQKB)10906390 035 $a(MiAaPQ)EBC515569 035 $a(Au-PeEL)EBL515569 035 $a(CaPaEBR)ebr10157864 035 $a(CaONFJC)MIL248508 035 $a(OCoLC)228144192 035 $a(EXLCZ)991000000000521668 100 $a20020118d2002 ub 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aUnderstanding colon cancer /$fA. Richard Adrouny 205 $a1st ed. 210 $aJackson $cUniversity Press of Mississippi$dc2002 215 $axi, 146 p. $cill 225 1 $aUnderstanding health and sickness series 300 $aIncludes index. 311 $a1-57806-473-2 311 $a1-57806-472-4 327 $aWho gets colon cancer and why -- The colon -- How colon cancer develops -- The "look" of colon cancer -- The "feel" of colon cancer -- Stages and prognosis of colon cancer -- Surgical treatment of colon cancer -- Treatment of later stages of colon cancer -- Prevention -- The future. 330 $aFor decades, while other cancers grabbed the headlines, colorectal cancer was quietly ignored. The lifetime risk of colorectal cancer in the general population is 2.5 to 5 percent. This means that twenty-five to fifty out of one thousand people will be stricken by this disease. Although data show that in America colorectal cancer incidence and mortality have been waning in recent decades, cancers of the colon and rectum still cause approximately 56,000 deaths annually. About 140,000 new cases are diagnosed each year. It is plainly evident that colon cancer constitutes a large portion of all new cancer cases, a little more than 10 percent. It is the fourth most frequent type. For the lay reader wishing to know more about this disease that has become more prominent in public attention, Understanding Colon Cancer gives concise information and explanation. It covers fundamental knowledge about occurrence, carcinogenesis, genetics, diagnosis, staging, prognosis, and treatment, as well as forecasting the kinds of diagnostic tests and treatments that may be developed. It reviews demographics, high-risk conditions, the sequence from bowel polyps to cancer, polyposis syndromes predisposing people to colorectal cancer, and the genetics of the disease. Discussed in full detail are the warning signs of the disease and the tests used for screening and diagnosis (fecal occult blood test, barium enema, sigmoidoscopy, and colonoscopy). The stages of the disease are examined, along with theories of how colon cancer spreads. Two chapters focus on treatments, including surgery and chemotherapy. An entire chapter devoted to early detection and prevention discusses standard ap-proaches, as well as such new or emerging strategies as vitamins, drugs, and genetic screening. What lies in the future for diagnostic testing and therapy? Understanding Colon Cancer concludes 330 8 $awith discussion that forecasts the potential of genetic screening and treatment, of "virtual colonoscopy," and of new chemotherapeutic drugs, vaccines, and monoclonal antibodies. Richard Adrouny has a private practice in Los Gatos, California, and serves as the director of medical oncology at the Community Hospital of Los Gatos-Saratoga. He is a clinical assistant professor of medicine at Stanford University School of Medicine and has been published in such periodicals as the New England Journal of Medicine , American Journal of Medicine , and Annals of Internal Medicine. 410 0$aUnderstanding health and sickness series. 606 $aColon (Anatomy)$xCancer$vPopular works 615 0$aColon (Anatomy)$xCancer 676 $a616.99/4347 700 $aAdrouny$b A. Richard$f1952-$01612421 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910809427203321 996 $aUnderstanding colon cancer$93941183 997 $aUNINA